These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27939297)
1. Health and Social Care workers' perceptions of NPS use in Northern Ireland. Campbell A; O Neill N; Higgins K Int J Drug Policy; 2017 Feb; 40():93-101. PubMed ID: 27939297 [TBL] [Abstract][Full Text] [Related]
2. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe. Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184 [TBL] [Abstract][Full Text] [Related]
3. Illicit drug users in Northern Ireland: perceptions and experiences of health and social care professionals. McLaughlin D; McKenna H; Leslie J; Moore K; Robinson J J Psychiatr Ment Health Nurs; 2006 Dec; 13(6):682-6. PubMed ID: 17087670 [TBL] [Abstract][Full Text] [Related]
4. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students. Champion KE; Teesson M; Newton NC Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894 [TBL] [Abstract][Full Text] [Related]
5. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives. Soussan C; Andersson M; Kjellgren A Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144 [TBL] [Abstract][Full Text] [Related]
6. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. Van Hout MC; Hearne E Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812 [TBL] [Abstract][Full Text] [Related]
7. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014. Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395 [TBL] [Abstract][Full Text] [Related]
8. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329 [TBL] [Abstract][Full Text] [Related]
9. New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries. Kurcevič E; Lines R Harm Reduct J; 2020 Nov; 17(1):94. PubMed ID: 33256747 [TBL] [Abstract][Full Text] [Related]
10. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations. Soussan C; Kjellgren A Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218 [TBL] [Abstract][Full Text] [Related]
11. New psychoactive substances legislation in Ireland - Perspectives from academia. Kavanagh PV; Power JD Drug Test Anal; 2014; 6(7-8):884-91. PubMed ID: 24478277 [TBL] [Abstract][Full Text] [Related]
12. Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior. Vreeker A; van der Burg BG; van Laar M; Brunt TM Addict Behav; 2017 Jul; 70():72-78. PubMed ID: 28214739 [TBL] [Abstract][Full Text] [Related]
13. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Larance B; Degenhardt L; Copeland J; Dillon P Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549 [TBL] [Abstract][Full Text] [Related]
14. A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms. Toth EC; Tegner J; Lauridsen S; Kappel N Harm Reduct J; 2016 Oct; 13(1):27. PubMed ID: 27717366 [TBL] [Abstract][Full Text] [Related]
15. "Someone Else's Problem": New Psychoactive Substances in the Online Hungarian Media. Kassai S; Rácz J; Nagy A; Bíbók T; Galambvári É; Kilián C; Gyarmathy VA J Psychoactive Drugs; 2017; 49(1):47-51. PubMed ID: 28010181 [TBL] [Abstract][Full Text] [Related]
16. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations. Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166 [TBL] [Abstract][Full Text] [Related]
17. 'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road. Barratt MJ; Lenton S; Maddox A; Allen M Int J Drug Policy; 2016 Sep; 35():50-7. PubMed ID: 27157539 [TBL] [Abstract][Full Text] [Related]
18. Community pharmacist experiences of providing needle and syringe programmes in Ireland. McVeigh J; Hearne E; Bates G; Van Hout MC Res Social Adm Pharm; 2017; 13(4):767-777. PubMed ID: 27568822 [TBL] [Abstract][Full Text] [Related]
19. Improving health and social care relationships for harm reduction. Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366 [TBL] [Abstract][Full Text] [Related]
20. Inpatient staff perceptions in providing care to individuals with co-occurring mental health problems and illicit substance use. Howard V; Holmshaw J J Psychiatr Ment Health Nurs; 2010 Dec; 17(10):862-72. PubMed ID: 21078001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]